Clinical Trials Directory

Trials / Completed

CompletedNCT03000764

RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer

Study of RNA and Heat Shock Protein (HSP) Derived Biomarkers in Radiation-induced Fibrosis in Patients Treated for Breast Cancer.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Institut de Cancérologie de Lorraine · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to seeking a molecular signature of pathological radiation induced fibrosis based on the response of skin fibroblasts after irradiation, comparing two groups of patients distinguished by their individual radiosensitivity. The signature will integrate recent insights in terms of alternative splicing of mRNAs and level of expression of non-coding RNAs, particularly long non-coding RNAs, snRNAs, snoRNAs and microRNAs. In each group each expression patterns of candidate HSP proteins potentially predictive of pathological radiation induced fibrosis (HSP27, HSP70, αβ crystalline) in the serum and on cell culture will be characterized.

Conditions

Interventions

TypeNameDescription
OTHERskin biopsiesBiopsies (12 G) will be performed : * in non-irradiated breast skin * in irradiated breast skin
OTHERblood samplesblood samples are collected: * 10 ml in EDTA tube * 2,5 ml in PAXgene Blood RNA tube * 4 ml in EDTA tube

Timeline

Start date
2017-05-10
Primary completion
2018-04-18
Completion
2018-04-25
First posted
2016-12-22
Last updated
2018-08-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03000764. Inclusion in this directory is not an endorsement.